| |
| |
|
| Insider
Information: |
Cavazza Paolo |
| Relationship: |
10% Owner |
| City: |
Lugano |
| State: |
V8 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
10,656,982 |
|
|
Indirect Shares
|
18,340,916 |
|
|
| Direct
Value |
$476,546 |
|
|
|
Indirect Value
|
$1,328,416 |
|
|
| Total
Shares |
28,997,898 |
|
|
| Total
Value |
$1,804,962 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -31.7%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Sciclone Pharmaceuticals Inc |
SCLN |
10% Owner |
2008-01-30 |
822,815 |
2008-01-30 |
8,635,831 |
Premium* |
|
|
Questcor Pharmaceuticals Inc |
QCOR |
10% Owner |
2005-04-15 |
8,643,397 |
2005-04-15 |
4,922,156 |
Premium* |
|
|
Regenerx Biopharmaceuticals Inc |
RGN |
10% Owner |
|
0 |
2021-06-30 |
1,500,000 |
Premium* |
|
|
Soligenix Inc Common |
SNGX |
10% Owner |
2010-06-18 |
1,190,770 |
2010-06-18 |
3,282,929 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
140 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2006-12-15 |
4 |
OE |
$2.50 |
$773,250 |
I/I |
309,300 |
765,841 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2006-03-14 |
4 |
OE |
$2.50 |
$125,000 |
I/I |
50,000 |
822,152 |
|
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2006-12-15 |
4 |
OE |
$2.50 |
$625,000 |
D/D |
250,000 |
822,815 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2006-06-13 |
4 |
OE |
$2.50 |
$87,750 |
I/I |
35,100 |
857,252 |
|
- |
|
| RGN |
Regenerx Biopharmaceutica... |
10% Owner |
– – • |
2005-06-22 |
4 |
B |
$3.25 |
$3,999,999 |
I/I |
1,230,769 |
923,077 |
1.5 |
- |
|
| RGN |
Regenerx Biopharmaceutica... |
10% Owner |
– – • |
2005-01-07 |
4 |
B |
$3.25 |
$3,199,999 |
I/I |
984,615 |
984,615 |
1.5 |
- |
|
| RGN |
Regenerx Biopharmaceutica... |
10% Owner |
– – • |
2005-08-01 |
4 |
B |
$0.00 |
$352,000 |
I/I |
110,000 |
984,615 |
1.5 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2006-06-16 |
4 |
OE |
$2.50 |
$567,250 |
I/I |
226,900 |
1,084,152 |
|
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2006-08-09 |
4 |
OE |
$2.50 |
$6,250 |
I/I |
2,500 |
1,086,652 |
|
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2006-09-15 |
4 |
OE |
$2.50 |
$118,750 |
I/I |
47,500 |
1,134,152 |
0 |
- |
|
| SNGX |
Soligenix Inc Common |
10% Owner |
– – • |
2008-11-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,190,770 |
|
- |
|
| RGN |
Regenerx Biopharmaceutica... |
10% Owner |
– – • |
2006-05-26 |
4 |
B |
$2.80 |
$350,000 |
I/I |
125,000 |
1,222,652 |
1.5 |
- |
|
| RGN |
Regenerx Biopharmaceutica... |
10% Owner |
– – • |
2021-06-30 |
4 |
B |
$0.20 |
$300,000 |
I/I |
1,500,000 |
1,500,000 |
1.5 |
% |
|
| RGN |
Regenerx Biopharmaceutica... |
10% Owner |
– – • |
2006-12-21 |
4 |
B |
$1.80 |
$2,999,999 |
I/I |
1,666,666 |
2,055,985 |
1.5 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2004-12-09 |
4 |
B |
$5.00 |
$12,500 |
I/I |
2,500 |
2,929,872 |
1.5 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2005-02-24 |
4 |
B |
$0.00 |
$63,932 |
I/I |
20,000 |
2,970,372 |
1.5 |
- |
|
| SNGX |
Soligenix Inc Common |
10% Owner |
– – • |
2010-06-18 |
4 |
B |
$0.21 |
$2,364,759 |
I/I |
11,535,409 |
3,282,929 |
1.5 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2004-11-18 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,410,941 |
|
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2005-03-30 |
4 |
OE |
$5.00 |
$2,500 |
I/I |
500 |
3,507,872 |
|
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2005-04-14 |
4 |
B |
$2.80 |
$70,389 |
I/I |
25,139 |
3,533,011 |
1.5 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2005-05-24 |
4 |
B |
$2.35 |
$117,470 |
I/I |
50,000 |
3,621,658 |
1.5 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2005-06-06 |
4 |
OE |
$2.50 |
$750,000 |
I/I |
300,000 |
4,128,558 |
|
- |
|
| RGN |
Regenerx Biopharmaceutica... |
10% Owner |
– – • |
2002-03-07 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,255,319 |
|
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2005-06-10 |
4 |
B |
$4.23 |
$422,755 |
I/I |
100,000 |
4,549,558 |
1.5 |
- |
|
| RGN |
Regenerx Biopharmaceutica... |
10% Owner |
– – • |
2008-02-29 |
4 |
B |
$1.00 |
$2,500,000 |
I/I |
2,500,000 |
4,555,985 |
1.5 |
- |
|
140 Records found
|
|
Page 4 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
